Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity
Launched by HOPITAL MONTFORT · May 31, 2024
Trial Information
Current as of February 08, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Background and rationale: This pilot trial aims to evaluate the feasibility and acceptability of a counselling intervention on physical activity in patients with liver steatosis (primary aim) and changes in molecular outcomes (exploratory aim).
Liver steatosis is the build-up of fat in the form of lipid droplets inside hepatocytes (liver cells). Although it is a form of energy storage, it is considered pathological when more than 5% of hepatocytes demonstrate fat infiltration on a liver biopsy or imaging (ultrasound, magnetic resonance, or computed tomography). Until recently, liver steato...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \>18 years of age,
- • confirmed MASLD or MASH without cirrhosis
- • access to a computer with an internet connection
- Exclusion Criteria:
- • liver disease from another cause,
- • the existence of cirrhosis on imaging or clinically,
- • weekly alcohol consumption over 50g,
- • having a contraindication to PA without medical clearance (the Get Active questionnaire from the Canadian Society for Exercise Physiology is used to determine if medical clearance is needed),
- • being already enrolled in a supervised exercise intervention or PA behaviour change intervention or currently meeting PA guidelines of 150 mins/week
- • the need for a wheelchair, cane, walker, or other support(s) to move
Trial Officials
Celine Fresne, MD
Principal Investigator
H[opital Montfort
About Hopital Montfort
Hôpital Montfort is a leading healthcare institution dedicated to providing high-quality medical services and advancing clinical research. Located in Ottawa, Canada, the hospital is recognized for its commitment to patient-centered care and innovation in health sciences. As a prominent sponsor of clinical trials, Hôpital Montfort collaborates with a multidisciplinary team of healthcare professionals to foster groundbreaking research aimed at improving treatment outcomes across various medical fields. The institution prioritizes ethical standards and patient safety, ensuring that all trials contribute valuable insights to the medical community while enhancing the overall health and well-being of the populations it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0